Feline asthma review sharpens diagnosis and treatment guidance
Bottom line
A new review in Veterinary Clinics of North America: Small Animal Practice updates the clinical picture for feline asthma, a common inflammatory airway disease in cats, and reinforces that diagnosis still depends on combining history, imaging, and airway sampling rather than relying on any single test. The review by Hannah Gareis and Bianka Schulz aligns with recent literature showing that feline asthma and chronic bronchitis often overlap under the broader umbrella of feline lower airway disease, while eosinophilic airway inflammation remains a key feature of asthma. Recent open-access work from the same research group also highlights that radiographic abnormalities can improve with treatment, though those imaging changes don’t always track neatly with clinical improvement. (epub.ub.uni-muenchen.de)
Why it matters: For veterinary professionals, the update is a reminder to keep a broad differential list when working up coughing or dyspneic cats. Asthma can resemble chronic bronchitis, heartworm-associated respiratory disease, or parasitic disease, and some cats in respiratory distress may not present with cough at all. Current guidance continues to support thoracic radiography plus bronchoalveolar lavage or other airway sampling when feasible, heartworm and parasite testing, environmental trigger reduction, glucocorticoids as the treatment backbone, and bronchodilators mainly when bronchoconstriction is part of the presentation. Inhaled steroids remain an important long-term option for reducing systemic adverse effects in appropriate patients. (cliniciansbrief.com)
What to watch: Expect continued interest in sharper phenotyping of feline lower airway disease, especially around allergen testing, imaging follow-up, and which cats benefit most from inhaled versus systemic therapy. (epub.ub.uni-muenchen.de)
Key facts
- Topic
- Feline asthma diagnosis and treatment
- Publication
- Veterinary Clinics of North America: Small Animal Practice
- Authors
- Hannah Gareis and Bianka Schulz
- Core diagnostic point
- Diagnosis depends on history, imaging, and airway sampling, not a single test
- Disease overlap
- Feline asthma and chronic bronchitis overlap under feline lower airway disease
- Key inflammatory feature
- Eosinophilic airway inflammation
- Treatment backbone
- Glucocorticoids
- Adjunct treatment
- Bronchodilators mainly when bronchoconstriction is present
- Monitoring finding
- In a 2023 prospective study of 24 cats, radiographic scores improved after treatment, but imaging improvement did not correlate directly with clinical score improvement
A newly published review on feline asthma diagnosis and treatment recommendations is bringing attention back to one of the most familiar, and still frustrating, respiratory syndromes in small animal practice. In Veterinary Clinics of North America: Small Animal Practice, Hannah Gareis and Bianka Schulz summarize the current approach to feline asthma, emphasizing that the disease remains common, clinically variable, and difficult to confirm without a structured workup that goes beyond symptoms alone. (em-consulte.com)
That message fits with where the field has been heading over the past several years. Feline asthma is increasingly discussed alongside chronic bronchitis under the broader category of feline lower airway disease, reflecting how much overlap exists in presentation and even in some diagnostic findings. In a 2023 prospective study, Gareis and colleagues followed 24 cats newly diagnosed with lower airway disease and found that all had radiographic abnormalities at presentation, and that radiographic scores improved significantly after treatment, even though imaging improvement did not correlate directly with clinical score improvement. (epub.ub.uni-muenchen.de)
The practical diagnostic challenge is that feline asthma can look like several other disorders. Recent clinical guidance notes that cough may be absent, meaning some cats present only in respiratory distress. Thoracic radiographs may show a diffuse bronchial or bronchointerstitial pattern, hyperinflation, or right middle lung lobe collapse, but up to 23% of asthmatic cats can have normal thoracic radiographs. That’s why current recommendations continue to stress airway cytology, typically through bronchoalveolar lavage, alongside efforts to rule out pulmonary parasites and heartworm-associated respiratory disease. (cliniciansbrief.com)
The treatment picture is more stable than the diagnostic one. Across the recent review literature, glucocorticoids remain the mainstay of therapy, with oral prednisolone often used initially and inhaled agents such as fluticasone or budesonide used for long-term control when cats and pet parents can manage inhaler delivery. Bronchodilators still have a role, but mainly as adjuncts, particularly for cats with acute bronchoconstriction or expiratory distress rather than as standalone chronic therapy. Environmental management also remains central, including reducing exposure to smoke, aerosols, dust, perfumes, molds, and other suspected triggers. (cliniciansbrief.com)
Research tied to Schulz’s group also suggests that the allergy story is more complicated than many clinicians or pet parents may expect. In a 2023 Frontiers study, investigators found no clear association between environmental exposure history and allergen test reactions in cats with feline lower airway disease, and they concluded that allergy test results should be interpreted cautiously and in the context of the individual patient. That supports a more restrained use of allergen testing as a decisive diagnostic tool, even though aeroallergens are still considered plausible triggers in at least some cases. (frontiersin.org)
Why it matters: For veterinary teams, this update is less about a dramatic therapeutic breakthrough and more about sharpening case management. It reinforces that feline asthma is not a one-test diagnosis, and that differentiating asthma from chronic bronchitis, heartworm-associated respiratory disease, and parasitic lung disease still matters because prognosis, monitoring, and treatment plans can diverge. It also supports a practical, staged approach: stabilize first in acute cases, confirm inflammation and rule-outs when possible, then transition appropriate patients toward long-term anti-inflammatory control with the least systemic burden that still works for the cat and pet parent. (cliniciansbrief.com)
The update may also encourage clinicians to use follow-up imaging more thoughtfully. The 2023 prospective data suggest radiographs can show objective improvement after treatment, even when those changes don’t mirror day-to-day symptom scores. That doesn’t make radiography a perfect monitoring tool, but it does suggest value in repeat imaging for selected cases, especially when clinical response is incomplete or the diagnosis remains uncertain. (epub.ub.uni-muenchen.de)
What to watch: The next phase of feline asthma work will likely focus on better disease phenotyping, including how to distinguish asthma from chronic bronchitis earlier, how much inhaled therapy can replace systemic treatment in routine practice, and whether biomarkers, allergen profiling, or microbiome findings can make diagnosis more precise. For now, the standard remains familiar: careful rule-outs, airway-focused diagnostics, anti-inflammatory treatment, and realistic long-term management plans. (epub.ub.uni-muenchen.de)